Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01080157 · ClinicalTrials.gov registry record

Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes

A clinical trial of Diabetes, sponsored by VeraLight.

Completed
Registry status
509
Enrollment target
12
Study locations

NCT01080157 is a study of Diabetes that has completed, run by VeraLight. The registered enrollment target is 509 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (83% lower). The trial reports 12 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01080157, a study of Diabetes, has completed, sponsored by VeraLight.

COMPLETED
Registry status
509 participants
Enrollment target
12
Study locations

Study Summary

The purpose of this research study is to test the safety and effectiveness of the SCOUT DS in measuring the concentration of substances (advanced glycation endproducts) in the skin. These substances have been found to be in higher concentrations in people with diabetes and high blood sugar. The SCOUT DS is being developed to help doctors measure these substances in skin and possibly help doctors diagnose diabetes.

Conditions Studied

Diabetes

Interventions

  • DEVICE SCOUT DS measurement

Study Locations (12)

Texas

  • Juno Research, LLC - Houston
  • Dynamed Clinical Research, LP - Houston
  • Radiant Research, Inc. - San Antonio - San Antonio

Illinois

  • Radiant Research, Inc. - Chicago - Chicago
  • Accelovance - Peoria, IL - Peoria

Alabama

  • Accelovance - Huntsville - Huntsville

California

  • Accelovance - San Diego, CA - San Diego

Kansas

  • Radiant Research, Inc. - Kansas City - Kansas City

Maryland

  • Accelovance - Rockville, MD - Rockville

Minnesota

  • Radiant Research, Inc. - Minneapolis - Minneapolis

New Mexico

  • Lovelace Scientific Resources, Inc. - Albuquerque

Trial Details

FieldValue
Enrollment Target 509 participants
Start Date 2010-03
Est. Completion 2010-12

Sponsor

VeraLight

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01080157

The ClinicalTrials.gov registry entry for NCT01080157 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 509 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (83% lower). The listed sponsor is VeraLight, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which SCOUT DS measurement is the first listed.

NCT01080157 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Texas, Illinois, Alabama.

Frequently Asked Questions

What is clinical trial NCT01080157 about?

NCT01080157 is a clinical study titled "Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes". The purpose of this research study is to test the safety and effectiveness of the SCOUT DS in measuring the concentration of substances (advanced glycation endproducts) in the skin. These substances have been found to be in higher concentrations in people with diabetes and high blood sugar. The SCOU...

What is the current status of trial NCT01080157?

This trial is currently completed. The enrollment target is 509 participants. The study started on 2010-03. Estimated completion is 2010-12.

What conditions does trial NCT01080157 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT01080157?

The interventions under investigation include: SCOUT DS measurement (DEVICE).

Who is sponsoring clinical trial NCT01080157?

This trial is sponsored by VeraLight, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01080157 being conducted?

This trial has 12 study locations across Alabama, California, Illinois, Kansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.